Is GOGY or JNJ a better dividend investment in 2026?

GOGY currently yields 11111.11% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: GOGY offers higher current income.

What is the dividend yield difference between GOGY and JNJ?

GOGY has a forward dividend yield of 11111.11% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 11108.98 percentage points.

Home › Compare › GOGY vs JNJ

GOGY vs JNJ: Dividend Comparison 2026

GOGY yields 11111.11% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GOGY wins by $155845322245618304.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GOGY

● Live price

11111.11%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$155845322245618304.00M

Annual income

$153,134,179,268,263,440,000,000.00

Full GOGY calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — GOGY vs JNJ

📍 GOGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GOGY	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GOGY + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GOGY pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GOGY

Annual income on $10K today (after 15% tax)

$944,444.44/yr

After 10yr DRIP, annual income (after tax)

$130,164,052,378,023,920,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, GOGY beats the other by $130,164,052,378,023,920,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GOGY + JNJ for your $10,000?

GOGY: 50%JNJ: 50%

100% JNJ50/50100% GOGY

Portfolio after 10yr

$77922661122809152.00M

Annual income

$76,567,089,634,131,720,000,000.00/yr

Blended yield

98.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GOGY

No analyst data

Altman Z

-418.5

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GOGY buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2026-01-23
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-12-18
Lloyd Doggett	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-12-09
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2025-11-20
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-11-13
Rich McCormick	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-11-05
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Jared Moskowitz	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-10-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGOGYJNJ

Forward yield	11111.11% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$155845322245618304.00M ✓	$30.3K
Annual income after 10y	$153,134,179,268,263,440,000,000.00 ✓	$4,689.40
Total dividends collected	$155665220770885760.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GOGY vs JNJ ($10,000, DRIP)

Year	GOGY Portfolio	GOGY Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,121,811	$1,111,111.11	$10,592	$272.30	+$1.11M → GOGY
2	$117,691,627	$116,491,288.80	$11,289	$357.73	+$117.68M → GOGY
3	$11,547,755,012	$11,421,824,971.17	$12,123	$472.89	+$11547.74M → GOGY
4	$1,059,734,753,299	$1,047,378,655,436.53	$13,141	$629.86	+$1059734.74M → GOGY
5	$90,963,535,000,723	$89,829,618,814,692.62	$14,408	$846.81	+$90963534.99M → GOGY
6	$7,303,524,681,616,793	$7,206,193,699,166,020.00	$16,021	$1,151.60	+$7303524681.60M → GOGY
7	$548,553,313,414,587,650	$540,738,542,005,257,700.00	$18,122	$1,588.22	+$548553313414.57M → GOGY
8	$38,543,778,083,006,005,000	$37,956,826,037,652,400,000.00	$20,930	$2,228.20	+$38543778083005.98M → GOGY
9	$2,533,778,483,509,246,600,000	$2,492,536,640,960,430,300,000.00	$24,792	$3,191.91	+$2533778483509246.50M → GOGY
10	$155,845,322,245,618,300,000,000	$153,134,179,268,263,440,000,000.00	$30,274	$4,689.40	+$155845322245618304.00M → GOGY

GOGY vs JNJ: Complete Analysis 2026

GOGY — Stock

Golden Grail Technology Corp. identifies and acquires brands in various beverage categories. Its portfolio includes beverage brands within energy drink and fruit essence water categories. The company was formerly known as Golden Energy Corp. and changed its name to Golden Grail Technology Corp. in November 2014. Golden Grail Technology Corp. was incorporated in 1985 and is based in Weston, Florida.

Full GOGY Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this GOGY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GOGY vs SCHD GOGY vs JEPI GOGY vs O GOGY vs KO GOGY vs MAIN GOGY vs ABBV GOGY vs MRK GOGY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.